az5140
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02224053)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- az5140
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02317016 | Phase 1 | Mar 10, 2015 | AstraZeneca |
| NCT02161770 | Phase 1 | Dec 22, 2014 | AstraZeneca |
| NCT02197234 | Phase 1 | Dec 22, 2014 | AstraZeneca |
| NCT02197247 | Phase 1 | Dec 4, 2014 | AstraZeneca |
| NCT02163733 | Phase 1 | Nov 14, 2014 | AstraZeneca |
| NCT02224053 | Phase 1 | Sep 1, 2014 | AstraZeneca |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 6 | 6 | 1 | 2014 |
1 organizations
Page 1 / 1